| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |